Search

Amanda C. Walke

Examiner (ID: 15144, Phone: (571)272-1337 , Office: P/1722 )

Most Active Art Unit
1722
Art Unit(s)
1722, 1737, 1752, 1795
Total Applications
2746
Issued Applications
2313
Pending Applications
137
Abandoned Applications
352

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18895622 [patent_doc_number] => 20240011107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => LIVE CELL ASSAY FOR PROTEASE INHIBITION [patent_app_type] => utility [patent_app_number] => 18/035021 [patent_app_country] => US [patent_app_date] => 2021-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10942 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035021 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/035021
LIVE CELL ASSAY FOR PROTEASE INHIBITION Nov 11, 2021 Pending
Array ( [id] => 17548436 [patent_doc_number] => 20220119777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-21 [patent_title] => CHEMILUMINESCENCE PHOTODYNAMIC VIRUS INACTIVATION OF RED BLOOD CELLS [patent_app_type] => utility [patent_app_number] => 17/506649 [patent_app_country] => US [patent_app_date] => 2021-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4437 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17506649 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/506649
CHEMILUMINESCENCE PHOTODYNAMIC VIRUS INACTIVATION OF RED BLOOD CELLS Oct 19, 2021 Abandoned
Array ( [id] => 17548502 [patent_doc_number] => 20220119843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-21 [patent_title] => RECOMBINANT ADENO-ASSOCIATED VIRUS COMPOSITIONS AND METHODS FOR PRODUCING SAME [patent_app_type] => utility [patent_app_number] => 17/502979 [patent_app_country] => US [patent_app_date] => 2021-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32637 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -46 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17502979 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/502979
RECOMBINANT ADENO-ASSOCIATED VIRUS COMPOSITIONS AND METHODS FOR PRODUCING SAME Oct 14, 2021 Pending
Array ( [id] => 17482626 [patent_doc_number] => 20220090130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => MODIFIED BACULOVIRUS SYSTEM FOR IMPROVED PRODUCTION OF CLOSED-ENDED DNA (ceDNA) [patent_app_type] => utility [patent_app_number] => 17/409774 [patent_app_country] => US [patent_app_date] => 2021-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20176 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17409774 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/409774
MODIFIED BACULOVIRUS SYSTEM FOR IMPROVED PRODUCTION OF CLOSED-ENDED DNA (ceDNA) Aug 22, 2021 Pending
Array ( [id] => 17212957 [patent_doc_number] => 20210346293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-11 [patent_title] => Lipid Vesicle for Oral Drug Delivery [patent_app_type] => utility [patent_app_number] => 17/384573 [patent_app_country] => US [patent_app_date] => 2021-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29398 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17384573 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/384573
Lipid Vesicle for Oral Drug Delivery Jul 22, 2021 Abandoned
Array ( [id] => 17200477 [patent_doc_number] => 20210340572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => HIGH-CONTENT IMAGING OF MICROFLUIDIC DEVICES [patent_app_type] => utility [patent_app_number] => 17/375324 [patent_app_country] => US [patent_app_date] => 2021-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40026 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -46 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17375324 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/375324
HIGH-CONTENT IMAGING OF MICROFLUIDIC DEVICES Jul 13, 2021 Pending
Array ( [id] => 17357068 [patent_doc_number] => 20220017864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => METHODS OF IDENTIFYING IMMUNOMODULATORY GENES [patent_app_type] => utility [patent_app_number] => 17/333903 [patent_app_country] => US [patent_app_date] => 2021-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50389 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17333903 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/333903
METHODS OF IDENTIFYING IMMUNOMODULATORY GENES May 27, 2021 Abandoned
Array ( [id] => 18483640 [patent_doc_number] => 20230210941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => COMPOSITIONS USEFUL IN TREATMENT OF KRABBE DISEASE [patent_app_type] => utility [patent_app_number] => 17/998330 [patent_app_country] => US [patent_app_date] => 2021-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63523 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998330 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/998330
COMPOSITIONS USEFUL IN TREATMENT OF KRABBE DISEASE May 10, 2021 Pending
Array ( [id] => 20478850 [patent_doc_number] => 12527305 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-20 [patent_title] => Porcine reproductive and respiratory syndrome virus resistant animals [patent_app_type] => utility [patent_app_number] => 17/242963 [patent_app_country] => US [patent_app_date] => 2021-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8174 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17242963 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/242963
Porcine reproductive and respiratory syndrome virus resistant animals Apr 27, 2021 Issued
Array ( [id] => 20479359 [patent_doc_number] => 12527822 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-20 [patent_title] => Methods, compositions, and kits for improving pancreatic beta cell viability and treating diseases or conditions related to beta cell destruction [patent_app_type] => utility [patent_app_number] => 17/234603 [patent_app_country] => US [patent_app_date] => 2021-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 38 [patent_no_of_words] => 6060 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17234603 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/234603
Methods, compositions, and kits for improving pancreatic beta cell viability and treating diseases or conditions related to beta cell destruction Apr 18, 2021 Issued
Array ( [id] => 18420192 [patent_doc_number] => 20230174653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => B7-H3 CHIMERIC ANTIGEN RECEPTORS [patent_app_type] => utility [patent_app_number] => 17/917198 [patent_app_country] => US [patent_app_date] => 2021-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36656 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917198 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/917198
B7-H3 CHIMERIC ANTIGEN RECEPTORS Apr 5, 2021 Pending
Array ( [id] => 19778730 [patent_doc_number] => 12227754 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-18 [patent_title] => Adenoviral expression vector and methods and cell lines for production [patent_app_type] => utility [patent_app_number] => 17/223785 [patent_app_country] => US [patent_app_date] => 2021-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17782 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17223785 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/223785
Adenoviral expression vector and methods and cell lines for production Apr 5, 2021 Issued
Array ( [id] => 16977884 [patent_doc_number] => 20210222121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => COMPOSITIONS AND METHODS FOR ENHANCING SPERM FUNCTION [patent_app_type] => utility [patent_app_number] => 17/221683 [patent_app_country] => US [patent_app_date] => 2021-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37712 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17221683 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/221683
COMPOSITIONS AND METHODS FOR ENHANCING SPERM FUNCTION Apr 1, 2021 Abandoned
Array ( [id] => 16975778 [patent_doc_number] => 20210220015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => COMPOSITIONS AND METHODS FOR ENHANCING SPERM FUNCTION [patent_app_type] => utility [patent_app_number] => 17/221682 [patent_app_country] => US [patent_app_date] => 2021-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37713 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17221682 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/221682
COMPOSITIONS AND METHODS FOR ENHANCING SPERM FUNCTION Apr 1, 2021 Abandoned
Array ( [id] => 17065804 [patent_doc_number] => 20210268019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => TARGETED EXPRESSION OF MICROBIAL CHOLESTEROL CATALYSIS GENES REDUCES EXCESS LIPID [patent_app_type] => utility [patent_app_number] => 17/187509 [patent_app_country] => US [patent_app_date] => 2021-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7369 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17187509 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/187509
TARGETED EXPRESSION OF MICROBIAL CHOLESTEROL CATALYSIS GENES REDUCES EXCESS LIPID Feb 25, 2021 Pending
Array ( [id] => 17197732 [patent_doc_number] => 20210337826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => MODIFICATION OF PROTEIN GLYCOSYLATION IN MICROORGANISMS [patent_app_type] => utility [patent_app_number] => 17/179100 [patent_app_country] => US [patent_app_date] => 2021-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14092 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17179100 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/179100
MODIFICATION OF PROTEIN GLYCOSYLATION IN MICROORGANISMS Feb 17, 2021 Abandoned
Array ( [id] => 19883046 [patent_doc_number] => 12268728 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-08 [patent_title] => Composition for preventing or treating pulmonary diseases comprising hyaluronan and proteoglycan link protein 1 [patent_app_type] => utility [patent_app_number] => 17/287443 [patent_app_country] => US [patent_app_date] => 2021-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6289 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17287443 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/287443
Composition for preventing or treating pulmonary diseases comprising hyaluronan and proteoglycan link protein 1 Feb 1, 2021 Issued
Array ( [id] => 17981310 [patent_doc_number] => 20220347346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-03 [patent_title] => MESENCHYMAL STEM CELL SHEET AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/430086 [patent_app_country] => US [patent_app_date] => 2021-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10423 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430086 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/430086
MESENCHYMAL STEM CELL SHEET AND USE THEREOF Jan 21, 2021 Pending
Array ( [id] => 16964225 [patent_doc_number] => 20210215724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-15 [patent_title] => METHOD OF TREATING PLASMA FOR USE [patent_app_type] => utility [patent_app_number] => 17/143699 [patent_app_country] => US [patent_app_date] => 2021-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4052 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17143699 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/143699
METHOD OF TREATING PLASMA FOR USE Jan 6, 2021 Abandoned
Array ( [id] => 18451927 [patent_doc_number] => 20230193206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => Method for Producing Serum for Culturing Mammalian Cells [patent_app_type] => utility [patent_app_number] => 17/789314 [patent_app_country] => US [patent_app_date] => 2020-12-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5965 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17789314 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/789314
Method for Producing Serum for Culturing Mammalian Cells Dec 24, 2020 Pending
Menu